SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-335724
Filing Date
2017-11-07
Accepted
2017-11-07 16:06:34
Documents
3
Period of Report
2017-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d489819d8k.htm 8-K 15521
2 EX-99.1 d489819dex991.htm EX-99.1 58049
3 GRAPHIC g489819g1107083802167.jpg GRAPHIC 2883
  Complete submission text file 0001193125-17-335724.txt   78856
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 171183419
SIC: 2834 Pharmaceutical Preparations